Article · 19 Jun 2026
Conference abstract
An open label study of modified matrix type TDDS of carvedilol and hydrochlorothiazide combination in healthy human volunteers
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Carvedilol (CRV) and hydrochlorothiazide (HCTZ) are the first line therapy for the treatment of uncomplicated essential hypertension. A major barrier to management of hypertension is the extent to which patient comply with the treatment regimen. The TDD system is unique and preferred system of delivery which provides nearly constant plasma level of medication over a prolonged period. Present study was designed to compare bioavailability, pharmacokinetic release profiles and adverse drug reaction along with phase I, open label, balanced, randomized, two- treatment, two- period, single- dose & crossover studies of CRV AND HCTZ containing modified transdermal patch with individual marketed oral formulation of same drugs in healthy, adult human subjects under fasting conditions. Pharmacokinetic parameters of patch were found to beCmax (45.127 ng/ml), Tmax (36 h), and AUC (2183.045 ng h/ml) which signified that the modified patch showed higher concentrations, stable drug release and extent of drug absorbed from patch was greater than tablets. Post dose (after transdermal patches application) the marked decrease in blood pressure was recorded. Patch did not affect the biochemical profile of healthy subjects and showed no hypersensitivity during clinical trial, indicating safety in this regard. The results suggested that transdermal drug delivery system of carvedilol and hydrochlorothiazide showed better safety and efficacy than oral treatment for hypertensive patients. PDF HTML
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmacovigilance.
Article · 19 Jun 2026
Strengthening Healthcare Outcomes Through Effective Drug Safety Practices
Article · 19 Jun 2026
Expanding Patient Care Through Clinical Pharmacy Services in Modern Healthcare
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmacovigilance
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Agrawal S. S”
